DESJARLAIS; John
Patent Applications and Registrations
Patent applications and USPTO patent grants for DESJARLAIS; John.The latest application filed is for "engineered il-2 fc fusion proteins".
Company Profile
46.68.133
- DESJARLAIS; John - Pasadena CA
- Desjarlais; John - Altadena CA
- Desjarlais; John - Monrovia CA
Patent Activity
| Patent | Date |
|---|---|
| ENGINEERED IL-2 Fc FUSION PROTEINS App 20220213162 - BERNETT; Matthew ; et al. | 2022-07-07 |
| Bispecific And Monospecific Antibodies Using Novel Anti-pd-1 Sequences App 20220204624 - Bernett; Matthew ; et al. | 2022-06-30 |
| IL15/IL15Ralpha HETERODIMERIC Fc-FUSION PROTEINS App 20220195048 - Bernett; Matthew ; et al. | 2022-06-23 |
| Heterodimeric antibodies that bind CD3 and CD38 Grant 11,352,442 - Bernett , et al. June 7, 2 | 2022-06-07 |
| Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20220162343 - Bernett; Matthew J. ; et al. | 2022-05-26 |
| Engineered IL-2 Fc fusion proteins Grant 11,319,355 - Bernett , et al. May 3, 2 | 2022-05-03 |
| Bispecific and monospecific antibodies using novel anti-PD-1 sequences Grant 11,312,770 - Bernett , et al. April 26, 2 | 2022-04-26 |
| Heterodimeric proteins Grant 11,299,554 - Moore , et al. April 12, 2 | 2022-04-12 |
| TARGETED HETERODIMERIC Fc FUSION PROTEINS CONTAINING IL-15 IL-15alpha AND ANTIGEN BINDING DOMAINS App 20220073588 - Bernett; Matthew J. ; et al. | 2022-03-10 |
| Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20220041757 - Bernett; Matthew J. ; et al. | 2022-02-10 |
| Il-15/il-15ra Heterodimeric Fc Fusion Proteins And Uses Thereof App 20220040264 - Bernett; Matthew ; et al. | 2022-02-10 |
| Bispecific checkpoint inhibitor antibodies Grant 11,236,170 - Bernett , et al. February 1, 2 | 2022-02-01 |
| Heterodimeric antibodies that bind CD3 and tumor antigens Grant 11,225,528 - Bernett , et al. January 18, 2 | 2022-01-18 |
| Bispecific Antibodies That Bind to CD38 and CD3 App 20210309762 - Bernett; Matthew ; et al. | 2021-10-07 |
| HETERODIMERIC HUMAN IgG1 POLYPEPTIDES WITH ISOELECTRIC POINT MODIFICATIONS App 20210284754 - Bernett; Matthew J. ; et al. | 2021-09-16 |
| Heterodimeric antibodies that bind CD3 and tumor antigens Grant 11,111,315 - Bernett , et al. September 7, 2 | 2021-09-07 |
| Bispecific Immunomodulatory Antibodies That Bind Costimulatory And Checkpoint Receptors App 20210253706 - Bernett; Matthew J. ; et al. | 2021-08-19 |
| Heterodimeric Antibodies That Bind Fibroblast Activation Protein App 20210253736 - Desjarlais; John ; et al. | 2021-08-19 |
| Modulation of T cells with bispecific antibodies and Fc fusions Grant 11,091,548 - Bernett , et al. August 17, 2 | 2021-08-17 |
| Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding domains Grant 11,084,863 - Bernett , et al. August 10, 2 | 2021-08-10 |
| Pd-1 Targeted Il-15/il-15ralpha Fc Fusion Proteins With Improved Properties App 20210230243 - Desjarlais; John ; et al. | 2021-07-29 |
| Immunoprotection of Therapeutic Moieties Using Enhanced Fc Regions App 20210205426 - Desjarlais; John ; et al. | 2021-07-08 |
| Optimized antibody variable regions Grant 11,053,316 - Moore , et al. July 6, 2 | 2021-07-06 |
| Heterodimeric Proteins App 20210171608 - Moore; Gregory ; et al. | 2021-06-10 |
| Novel Heterodimeric Proteins App 20210163627 - Moore; Gregory ; et al. | 2021-06-03 |
| OPTIMIZED Fc VARIANTS App 20210139600 - Lazar; Gregory ; et al. | 2021-05-13 |
| Fc VARIANTS WITH ALTERED BINDING TO FcRn App 20210115147 - Chamberlain; Aaron Keith ; et al. | 2021-04-22 |
| Heterodimeric antibodies that bind fibroblast activation protein Grant 10,982,006 - Desjarlais , et al. April 20, 2 | 2021-04-20 |
| Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors Grant 10,981,992 - Bernett , et al. April 20, 2 | 2021-04-20 |
| Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20210102003 - Bernett; Matthew J. ; et al. | 2021-04-08 |
| Complement Component C5 Antibodies App 20210101965 - BACIU; Peter C. ; et al. | 2021-04-08 |
| HETERODIMERIC IgG-LIKE BISPECIFIC ANTIBODIES App 20210102002 - Bernett; Matthew ; et al. | 2021-04-08 |
| Optimized anti-CD3 variable regions Grant 10,968,276 - Moore , et al. April 6, 2 | 2021-04-06 |
| Bispecific Immunomodulatory Antibodies That Bind Costimulatory And Checkpoint Receptors App 20210095030 - Bernett; Matthew ; et al. | 2021-04-01 |
| Il-7-fc-fusion Proteins App 20210070824 - Bernett; Matthew ; et al. | 2021-03-11 |
| Heterodimeric antibodies that bind CD3 and tumor antigens Grant 10,913,803 - Bernett , et al. February 9, 2 | 2021-02-09 |
| Heterodimeric antibodies that bind CD3 and tumor antigens Grant 10,889,653 - Bernett , et al. January 12, 2 | 2021-01-12 |
| Bispecific antibodies that bind to CD38 and CD3 Grant 10,858,451 - Bernett , et al. December 8, 2 | 2020-12-08 |
| Heterodimeric proteins Grant 10,858,417 - Moore , et al. December 8, 2 | 2020-12-08 |
| Heterodimeric human IgG1 polypeptides with isoelectric point modifications Grant 10,851,178 - Bernett , et al. December 1, 2 | 2020-12-01 |
| Modulation Of T Cells With Bispecific Antibodies And Fc Fusions App 20200339624 - Chu; Seung ; et al. | 2020-10-29 |
| Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors Grant 10,793,632 - Bernett , et al. October 6, 2 | 2020-10-06 |
| Bispecific checkpoint inhibitor antibodies Grant 10,787,518 - Bernett , et al. September 29, 2 | 2020-09-29 |
| Complement component C5 antibodies Grant 10,752,678 - Baciu , et al. A | 2020-08-25 |
| Heterodimeric proteins Grant 10,738,133 - Moore , et al. A | 2020-08-11 |
| Heterodimeric Antibodies That Bind Cd3 And Psma App 20200216559 - Moore; Gregory ; et al. | 2020-07-09 |
| Heterodimeric Antibodies That Bind Cd3 And Cd38 App 20200199251 - Bernett; Matthew J. ; et al. | 2020-06-25 |
| Heterodimeric Antibodies That Bind Fibroblast Activation Protein App 20200165356 - Desjarlais; John ; et al. | 2020-05-28 |
| BISPECIFIC HETERODIMERIC FUSION PROTEINS CONTAINING IL-15 - IL-15Ralpha Fc-FUSION PROTEINS AND IMMUNE CHECKPOINT ANTIBODY FRAGME App 20200123259 - Bernett; Matthew ; et al. | 2020-04-23 |
| Fc variants with increased affinity for Fc.gamma.RIIc Grant 10,584,176 - Lazar , et al. | 2020-03-10 |
| Heterodimeric Proteins App 20200048370 - Moore; Gregory ; et al. | 2020-02-13 |
| IL15/IL15Ralpha HETERODIMERIC Fc-FUSION PROTEINS App 20200040083 - Bernett; Matthew ; et al. | 2020-02-06 |
| Bispecific heterodimeric fusion proteins containing IL-15-IL-15R.alpha. Fc-fusion proteins and PD-1 antibody fragments Grant 10,550,185 - Bernett , et al. Fe | 2020-02-04 |
| Targeting regulatory T cells with heterodimeric proteins Grant 10,544,187 - Chu , et al. Ja | 2020-01-28 |
| Heterodimeric antibodies that bind CD3 and CD38 Grant 10,526,417 - Bernett , et al. J | 2020-01-07 |
| Targeting regulatory T cells with heterodimeric proteins Grant 10,519,242 - Chu , et al. Dec | 2019-12-31 |
| Bispecific Checkpoint Inhibitor Antibodies App 20190389954 - Bernett; Matthew ; et al. | 2019-12-26 |
| PD-1 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15Ra Fc-FUSION PROTEINS AND PD-1 ANTIGEN BINDING DOMAINS AND USE App 20190389933 - Bernett; Matthew ; et al. | 2019-12-26 |
| Bispecific Checkpoint Inhibitor Antibodies App 20190382495 - Bernett; Matthew ; et al. | 2019-12-19 |
| IL15/IL15R.alpha. heterodimeric Fc-fusion proteins Grant 10,501,543 - Bernett , et al. Dec | 2019-12-10 |
| Il-15/il-15ra Heterodimeric Fc Fusion Proteins And Uses Thereof App 20190365861 - Bernett; Matthew ; et al. | 2019-12-05 |
| TIM-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15RA Fc-FUSION PROTEINS AND TIM-3 ANTIGEN BINDING DOMAINS App 20190359684 - Bernett; Matthew ; et al. | 2019-11-28 |
| Heterodimeric proteins Grant 10,487,155 - Moore , et al. Nov | 2019-11-26 |
| LAG-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15RA Fc-FUSION PROTEINS AND LAG-3 ANTIGEN BINDING DOMAINS App 20190352362 - Bernett; Matthew ; et al. | 2019-11-21 |
| Trispecific Antibodies App 20190352416 - Moore; Gregory ; et al. | 2019-11-21 |
| Heterodimeric proteins Grant 10,472,427 - Desjarlais , et al. Nov | 2019-11-12 |
| Trispecific antibodies Grant 10,428,155 - Moore , et al. October 1, 2 | 2019-10-01 |
| Bispecific Immunomodulatory Antibodies That Bind Costimulatory And Checkpoint Receptors App 20190270816 - Bernett; Matthew ; et al. | 2019-09-05 |
| Optimized Antibody Variable Regions App 20190270810 - Moore; Gregory ; et al. | 2019-09-05 |
| Bispecific And Monospecific Antibodies Using Novel Anti-pd-1 Sequences App 20190263909 - Bernett; Matthew ; et al. | 2019-08-29 |
| ENGINEERED IL-2 Fc FUSION PROTEINS App 20190241638 - Bernett; Matthew ; et al. | 2019-08-08 |
| Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20190202938 - Bernett; Matthew J. ; et al. | 2019-07-04 |
| Modulation Of T Cells With Bispecific Antibodies And Fc Fusions App 20190194325 - Bernett; Matthew ; et al. | 2019-06-27 |
| Heterodimeric proteins Grant 10,287,364 - Moore , et al. | 2019-05-14 |
| Heterodimeric antibodies that bind CD3 and tumor antigens Grant 10,259,887 - Bernett , et al. | 2019-04-16 |
| Heterodimeric antibodies that bind CD3 and PSMA Grant 10,227,410 - Moore , et al. | 2019-03-12 |
| Modulation of T cells with bispecific antibodies and FC fusions Grant 10,227,411 - Bernett , et al. | 2019-03-12 |
| Fc Variants with Increased Affinity for FcyRIIc App 20190071512 - Lazar; Gregory ; et al. | 2019-03-07 |
| Optimized Fc variants and methods for their generation Grant 10,184,000 - Lazar , et al. Ja | 2019-01-22 |
| Optimized Fc variants and methods for their generation Grant 10,183,999 - Lazar , et al. Ja | 2019-01-22 |
| TARGETED HETERODIMERIC Fc FUSION PROTEINS CONTAINING IL-15 IL-15alpha AND ANTIGEN BINDING DOMAINS App 20190016778 - Bernett; Matthew J. ; et al. | 2019-01-17 |
| Novel Immunoglobulin Variants App 20180360981 - Lazar; Gregory Alan ; et al. | 2018-12-20 |
| Optimized antibody variable regions Grant 10,131,710 - Moore , et al. November 20, 2 | 2018-11-20 |
| Fc variants with increased affinity for FcyRIIc Grant 10,113,001 - Lazar , et al. October 30, 2 | 2018-10-30 |
| Heterodimeric Antibodies That Bind Cd3 And Cd38 App 20180305465 - Stevens; Jennitte Leann ; et al. | 2018-10-25 |
| Heterodimeric proteins Grant 10,106,624 - Moore , et al. October 23, 2 | 2018-10-23 |
| Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20180282432 - Bernett; Matthew J. ; et al. | 2018-10-04 |
| Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20180223000 - Bernett; Matthew J. ; et al. | 2018-08-09 |
| Complement Component C5 Antibodies App 20180222969 - Baciu; Peter C. ; et al. | 2018-08-09 |
| Novel Heterodimeric Proteins App 20180215834 - Desjarlais; John ; et al. | 2018-08-02 |
| OPTIMIZED Fc VARIANTS App 20180208668 - Lazar; Gregory ; et al. | 2018-07-26 |
| Rapid Clearance Of Antigen Complexes Using Novel Antibodies App 20180201686 - Moore; Gregory L. ; et al. | 2018-07-19 |
| Fc VARIANTS WITH ALTERED BINDING TO FcRn App 20180162946 - CHAMBERLAIN; Aaron ; et al. | 2018-06-14 |
| Novel Heterodimeric Proteins App 20180142040 - Moore; Gregory ; et al. | 2018-05-24 |
| Bispecific Immunomodulatory Antibodies That Bind Costimulatory And Checkpoint Receptors App 20180127501 - Bernett; Matthew ; et al. | 2018-05-10 |
| Bispecific Checkpoint Inhibitor Antibodies App 20180118836 - Bernett; Matthew ; et al. | 2018-05-03 |
| IL15/IL15Ralpha HETERODIMERIC Fc-FUSION PROTEINS App 20180118805 - Bernett; Matthew ; et al. | 2018-05-03 |
| BISPECIFIC HETERODIMERIC FUSION PROTEINS CONTAINING IL-15 - IL-15Ralpha Fc-FUSION PROTEINS AND IMMUNE CHECKPOINT ANTIBODY FRAGMENTS App 20180118828 - Bernett; Matthew ; et al. | 2018-05-03 |
| Bispecific Antibodies That Bind to CD38 and CD3 App 20180094079 - Bernett; Matthew J. ; et al. | 2018-04-05 |
| Nucleic acids encoding complement component C5 antibodies Grant 9,932,395 - Baciu , et al. April 3, 2 | 2018-04-03 |
| Heterodimeric Proteins App 20180037668 - Moore; Gregory ; et al. | 2018-02-08 |
| Heterodimeric antibodies to CD3 X CD123 Grant 9,856,327 - Bernett , et al. January 2, 2 | 2018-01-02 |
| Heterodimeric antibodies to CD3 X CD20 Grant 9,850,320 - Bernett , et al. December 26, 2 | 2017-12-26 |
| Bispecific antibodies that bind to CD38 and CD3 Grant 9,822,186 - Bernett , et al. November 21, 2 | 2017-11-21 |
| Heterodimeric Antibodies That Bind Cd3 And Psma App 20170320947 - Moore; Gregory ; et al. | 2017-11-09 |
| Complement Component C5 Antibodies App 20170306007 - Baciu; Peter C. ; et al. | 2017-10-26 |
| Rapid Clearance Of Antigen Complexes Using Novel Antibodies App 20170247470 - Moore; Gregory L. ; et al. | 2017-08-31 |
| Rapid clearance of antigen complexes using novel antibodies Grant 9,738,722 - Moore , et al. August 22, 2 | 2017-08-22 |
| Complement component C5 antibodies Grant 9,701,743 - Baciu , et al. July 11, 2 | 2017-07-11 |
| Novel Immunoglobulin Variants App 20170166655 - Lazar; Gregory Alan ; et al. | 2017-06-15 |
| Optimized Fc variants Grant 9,663,582 - Lazar , et al. May 30, 2 | 2017-05-30 |
| Optimized Fc variants Grant 9,657,106 - Lazar , et al. May 23, 2 | 2017-05-23 |
| Heterodimeric proteins Grant 9,650,446 - Moore , et al. May 16, 2 | 2017-05-16 |
| Heterodimeric proteins Grant 9,605,084 - Moore , et al. March 28, 2 | 2017-03-28 |
| Heterodimeric Antibodies To Cd3 X Cd123 App 20170081420 - Bernett; Matthew J. ; et al. | 2017-03-23 |
| Heterodimeric Antibodies To Cd3 X Cd123 App 20170081424 - Bernett; Matthew J. ; et al. | 2017-03-23 |
| Modulation Of T Cells With Bispecific Antibodies And Fc Fusions App 20170037131 - Bernett; Matthew ; et al. | 2017-02-09 |
| Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20160355608 - Bernett; Matthew J. ; et al. | 2016-12-08 |
| Trispecific antibodies App 20160355600 - Moore; Gregory ; et al. | 2016-12-08 |
| OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION App 20160347825 - Lazar; Gregory Alan ; et al. | 2016-12-01 |
| OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION App 20160347837 - Lazar; Gregory Alan ; et al. | 2016-12-01 |
| Optimized Fc Variants App 20160340436 - Lazar; Gregory ; et al. | 2016-11-24 |
| OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION App 20160318993 - Lazar; Gregory Alan ; et al. | 2016-11-03 |
| OPTIMIZED Fc VARIANTS App 20160304589 - LAZAR; Gregory ; et al. | 2016-10-20 |
| Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20160229924 - Bernett; Matthew J. ; et al. | 2016-08-11 |
| Heterodimeric Antibodies That Bind Cd3 And Cd38 App 20160215063 - Bernett; Matthew J. ; et al. | 2016-07-28 |
| Heterodimeric Antibodies Including Binding To Cd8 App 20160176969 - Bernett; Matthew J. ; et al. | 2016-06-23 |
| Optimized FC variants and methods for their generation Grant 9,353,187 - Lazar , et al. May 31, 2 | 2016-05-31 |
| Antibodies With Modified Isoelectric Points And Immunofiltering App 20160068588 - Bernett; Matthew J. ; et al. | 2016-03-10 |
| Rapid Clearance Of Antigen Complexes Using Novel Antibodies App 20160060360 - Moore; Gregory L. ; et al. | 2016-03-03 |
| Compositions and methods for treating IgE-mediated disorders Grant 9,266,966 - Desjarlais , et al. February 23, 2 | 2016-02-23 |
| Compositions and methods for treating IgE-mediated disorders Grant 9,221,916 - Desjarlais , et al. December 29, 2 | 2015-12-29 |
| Optimized Fc variants and methods for their generation Grant 9,193,798 - Lazar , et al. November 24, 2 | 2015-11-24 |
| OPTIMIZED Fc VARIANTS App 20150315284 - Lazar; Gregory Alan ; et al. | 2015-11-05 |
| Bispecific antibodies that bind to CD38 and CD3 App 20150307629 - Bernett; Matthew ; et al. | 2015-10-29 |
| Complement Component C5 Antibodies App 20150239966 - Baciu; Peter C. ; et al. | 2015-08-27 |
| Fc Variants with Increased Affinity for FcyRIIc App 20150232567 - LAZAR; GREGORY ; et al. | 2015-08-20 |
| Compositions and methods for treating IgE-mediated disorders Grant 9,062,117 - Desjarlais , et al. June 23, 2 | 2015-06-23 |
| Optimized Fc variants Grant 9,051,373 - Lazar , et al. June 9, 2 | 2015-06-09 |
| Fc VARIANTS WITH ALTERED BINDING TO FcRn App 20150152183 - Chamberlain; Aaron ; et al. | 2015-06-04 |
| NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS App 20150139985 - DESJARLAIS; JOHN ; et al. | 2015-05-21 |
| NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS App 20150093379 - DESJARLAIS; JOHN ; et al. | 2015-04-02 |
| OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION App 20150079082 - LAZAR; Gregory Alan ; et al. | 2015-03-19 |
| Novel Immunoglobulin Variants App 20150071948 - Lazar; Gregory Alan ; et al. | 2015-03-12 |
| OPTIMIZED Fc VARIANTS App 20150030592 - Lazar; Gregory ; et al. | 2015-01-29 |
| OPTIMIZED Fc VARIANTS App 20150031862 - LAZAR; Gregory ; et al. | 2015-01-29 |
| OPTIMIZED Fc VARIANTS App 20150010543 - Lazar; Gregory ; et al. | 2015-01-08 |
| OPTIMIZED Fc VARIANTS App 20150010550 - Lazar; Gregory ; et al. | 2015-01-08 |
| Optimized Antibody Variable Regions App 20140377270 - Moore; Gregory ; et al. | 2014-12-25 |
| OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION App 20140370021 - Lazar; Gregory Alan ; et al. | 2014-12-18 |
| Heterodimeric Proteins App 20140363426 - MOORE; GREGORY ; et al. | 2014-12-11 |
| Methods Of Purifying Heterodimeric Proteins Using Immunoglobulin Class Switching App 20140356381 - Moore; Gregory ; et al. | 2014-12-04 |
| Novel Heterodimeric Proteins App 20140322217 - MOORE; Gregory ; et al. | 2014-10-30 |
| Optimized Fc variants and methods for their generation Grant 8,858,937 - Lazar , et al. October 14, 2 | 2014-10-14 |
| Novel Heterodimeric Proteins App 20140294835 - Moore; Gregory ; et al. | 2014-10-02 |
| Heterodimeric Proteins App 20140294823 - Moore; Gregory ; et al. | 2014-10-02 |
| Targeting Regulatory T Cells With Heterodimeric Proteins App 20140294759 - Chu; Seung ; et al. | 2014-10-02 |
| Novel Heterodimeric Proteins App 20140288275 - Moore; Gregory ; et al. | 2014-09-25 |
| Optimized Fc variants and methods for their generation Grant 8,809,503 - Lazar , et al. August 19, 2 | 2014-08-19 |
| Optimized Fc variants Grant 8,802,823 - Lazar , et al. August 12, 2 | 2014-08-12 |
| Rapid Clearance Of Antigen Complexes Using Novel Antibodies App 20140212435 - Moore; Gregory L. ; et al. | 2014-07-31 |
| Rapid Clearance Of Antigen Complexes Using Novel Antibodies App 20140212436 - Moore; Gregory L. ; et al. | 2014-07-31 |
| Optimized Fc variants Grant 8,753,629 - Lazar , et al. June 17, 2 | 2014-06-17 |
| Optimized Fc variants Grant 8,753,628 - Lazar , et al. June 17, 2 | 2014-06-17 |
| Engineered Immunoglobulins With Extended In Vivo Half-life App 20140161790 - Desjarlais; John ; et al. | 2014-06-12 |
| Fc variants having increased affinity for fcyrllc Grant 8,735,545 - Lazar , et al. May 27, 2 | 2014-05-27 |
| Optimized Fc Variants Grant 8,735,547 - Lazar , et al. May 27, 2 | 2014-05-27 |
| OPTIMIZED Fc VARIANTS App 20140073768 - Lazar; Gregory Alan ; et al. | 2014-03-13 |
| Optimized Fc Variants App 20130302315 - Lazar; Gregory Alan ; et al. | 2013-11-14 |
| Optimized Fc Variants App 20130273043 - Lazar; Gregory Alan ; et al. | 2013-10-17 |
| Optimized Fc Variants App 20130261289 - Lazar; Gregory Alan ; et al. | 2013-10-03 |
| Optimized Fc Variants and Methods for Their Generation App 20130243762 - Lazar; Gregory Alan ; et al. | 2013-09-19 |
| Optimized Fc Variants App 20130209457 - Lazar; Gregory Alan ; et al. | 2013-08-15 |
| Novel Compositions and Methods for Treating IgE-Mediated Disorders App 20130177553 - Desjarlais; John ; et al. | 2013-07-11 |
| Method for Purifying Antibodies App 20130171095 - BERNETT; Matthew J. ; et al. | 2013-07-04 |
| Optimized Fc Variants and Methods for Their Generation App 20130156758 - Lazar; Gregory Alan ; et al. | 2013-06-20 |
| Optimized Fc Variants and Methods For Their Generation App 20130156754 - Lazar; Gregory Alan ; et al. | 2013-06-20 |
| Immunoprotection of Therapeutic Moieties Using Enhanced Fc Regions App 20110189178 - Desjarlais; John ; et al. | 2011-08-04 |
| Protein design automation for designing protein libraries with altered immunogenicity App 20030022285 - Chirino, Arthur J. ; et al. | 2003-01-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 